AgBiotech Startup Brings Plant Immunity Back to Life with AI-Driven Gene Editing

Agricultural biotechnology startup Resurrect Bio is developing disease resistant crops using gene editing and its proprietary artificial intelligence (AI) platform, FloraFold. The AI-driven platform, specifically tailored to plants, aims to reactivate immune functions suppressed by pathogens or lost through decades of intensive breeding for yield.

The London-based company, a spin-out from The Sainsbury Laboratory, addresses a critical vulnerability in modern agriculture, the silencing of plant immune receptors by evolving pathogens. By leveraging deep learning, the FloraFold platform predicts the precise, minimal genetic modifications needed to break the chemical grip that pathogens use to disable a plant's internal defenses. Unlike traditional GMO approaches that introduce foreign DNA, Resurrect Bio focuses on making targeted, single-nucleotide edits to native genes, effectively "resurrecting" the plant's own ability to identify and fight off infections such as soybean cyst nematode and late blight.

This breakthrough technology promises to significantly reduce the industry's reliance on chemical pesticides while accelerating the development of resilient crop varieties by up to five times compared to conventional breeding. With the new capital, Resurrect Bio plans to expand its research team and push multiple resistance traits toward commercial partnerships. As global food security faces increasing pressure from climate change and pesticide-resistant diseases, the company's approach offers a scalable, sustainable path toward more durable agricultural systems.

For more details, read the article in AgTechNavigator.com.